Jean Deleage insider trades: Acelrx Pharmaceuticals (ACRX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jean reports to the SEC
and 8 more companies
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 16, 2011 | ACRX | ↑ Buy | 680,000 | $5.00 | $3.4M | Direct | Feb 18, 2011 (2d) |
| Oct 27, 2010 | AEGR | ↑ Buy | 315,789 | $9.50 | $3.0M | Direct | Oct 27, 2010 (0d) |
| Jun 30, 2010 | SNSS | ↑ Buy | 10,910,596 | $0.28 | $3.0M | Direct | Jul 2, 2010 (2d) |
| Jun 30, 2010 | SNSS | ↑ Buy | 1,001,628 | $0.28 | $275K | Indirect | Jul 2, 2010 (2d) |
| Dec 14, 2009 | SNSS | ↓ Sell | 2,044,750 | $2.01 | $4.1M | Direct | Dec 16, 2009 (2d) |
| Dec 14, 2009 | SNSS | ↓ Sell | 187,714 | $2.01 | $377K | By Fund | Dec 16, 2009 (2d) |
| Oct 16, 2009 | CORT | ↑ Buy | 337,245 | $1.38 | $465K | Direct | Oct 20, 2009 (4d) |
| Oct 16, 2009 | CORT | ↑ Buy | 12,406 | $1.38 | $17K | By Side Fund | Oct 20, 2009 (4d) |
| Oct 5, 2009 | THLD | ↑ Buy | 239,768 | $1.91 | $458K | Direct | Oct 6, 2009 (1d) |
| Oct 5, 2009 | THLD | ↑ Buy | 22,012 | $1.91 | $42K | Indirect | Oct 6, 2009 (1d) |
| Sep 8, 2009 | TPTX | ↓ Sell | 717,837 | $0.22 | $161K | Indirect | Sep 8, 2009 (0d) |
| Sep 8, 2009 | TPTX | ↓ Sell | 717,837 | $0.22 | $161K | Indirect | Sep 8, 2009 (0d) |
| Mar 25, 2008 | CORT | ↑ Buy | 1,059,135 | $2.77 | $2.9M | By Fund | Mar 26, 2008 (1d) |
| Dec 1, 2006 | CYCC | ↓ Sell | 114,239 | $6.33 | $723K | Indirect | Dec 4, 2006 (3d) |
| May 5, 2006 | KOSN | ↑ Buy | 300,000 | $1500000.00 | $450.00B | Indirect | May 9, 2006 (4d) |
| Oct 14, 2005 | CTRX | ↓ Sell | 166,937 | $13.00 | $2.2M | Indirect | Oct 18, 2005 (4d) |
| Oct 12, 2005 | CTRX | ↓ Sell | 247,314 | $13.00 | $3.2M | Indirect | Oct 14, 2005 (2d) |
| Jul 27, 2005 | RIGL | ↓ Sell | 171,997 | $20.33 | $3.5M | Indirect | Jul 27, 2005 (0d) |
| Jul 25, 2005 | RIGL | ↓ Sell | 6,400 | $20.37 | $130K | Indirect | Jul 25, 2005 (0d) |
| Jul 21, 2005 | RIGL | ↓ Sell | 586 | $20.75 | $12K | Indirect | Jul 22, 2005 (1d) |
| Jul 20, 2005 | RIGL | ↓ Sell | 148,043 | $20.75 | $3.1M | Indirect | Jul 20, 2005 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Jean Deleage's insider trades
Jean Deleage is a 10% owner of Acelrx Pharmaceuticals (ACRX). Since Jul 20, 2005, Jean has reported 10 open-market purchases worth $450.01B and 11 sales worth $17.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (22 filings), other transactions (11 filings), conversions (4 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.